Sourcing · Regulatory · continued

How compounding permissions changed when supply normalised posts 31–35

Sourcing › Regulatory personal import EMA compounding research use only Solved

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1 · go to the accepted answer.

ZieglerTL3Regular16 Mar 2025#31

Answering the question post #28 raises rather than the one it answers.

I have no financial interest in anything named in this thread and I want to say so before I comment on compounding permissions, because it is the sort of subject where it matters.

0 likes 16mo

m.ramosTL219 Mar 2025#32

That is a cleaner way of putting what I was circling around.

19 likes 16mo

careful_beginnerTL1Member21 Mar 2025#33

s.karlsen_rph, post #6: Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported. That has been true for the cases I have seen and I have not seen many. Go to post

Genuine question rather than a rhetorical one: has anyone here actually observed compounding permissions, as opposed to read about it? The thread is long and I cannot tell.

8 likes in reply to #6 16mo

m.ilungaTL223 Mar 2025#34

Post #33 is the version of this I will quote in future. One addition.

Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict and vary by jurisdiction. Generalising from one country's rules to another's is unreliable.

Not a strong opinion, just a consistent one.

2 likes 16mo

m.stephanopoulosTL3Regular26 Mar 2025#35

Grateful for the specificity. Vague answers to this question are what sent me looking.

0 likes 16mo

This topic was referenced in

Why a compound being unapproved is not the same as being illegal to possessSourcing › Regulatory · 78 replies

Suggested topics

Topic	Participants	Replies	Views	Activity
Research-use-only labelling: what it means and what it does not Sourcing › Regulatory compounding research use only EMA FDA Posting this under the heading it deserves: Research-use-only labelling: what it means and what it does not Everything below is what sits behind that. A labelling question, and I would like the answer to be…	+100	110	37k	5mo
Reading a regulatory notice rather than an article about it Sourcing › Regulatory compounding personal import EMA Posting this under the heading it deserves: Reading a regulatory notice rather than an article about it Everything below is what sits behind that. Posting a small dataset on reading a regulatory notice. It is…		2	2.9k	5mo
Coming back to: Research-use-only labelling: what it means and what it does not Sourcing › Regulatory MHRA personal import research use only Solved Research-use-only labelling: what it means and what it does not — setting out what I have, and where I think it stops being reliable. A labelling question, and I would like the answer to be about what the…	+45	50	39k	20mo
Pharmaceutical compounding rules, summarised from primary sources Sourcing › Regulatory MHRA EMA research use only Closed Pharmaceutical compounding rules, summarised from primary sources — setting out what I have, and where I think it stops being reliable. Asking what a regulator's document actually says, since the summaries of…	+135	163	46k	17mo
Why a compound being unapproved is not the same as being illegal to possess Sourcing › Regulatory FDA MHRA research use only EMA Why a compound being unapproved is not the same as being illegal to possess I have a specific reason for asking rather than idle curiosity, and the context is below. Collecting what is known about compound…	+72	78	23k	3mo

Related topics — sharing the tags personal import, EMA, compounding

Topic	Participants	Replies	Views	Activity
Naming conventions for research peptides and the confusion they cause Compounds › Other compounds custom synthesis mislabelling research use only needs a source Posting this under the heading it deserves: Naming conventions for research peptides and the confusion they cause Everything below is what sits behind that. I was wrong about naming conventions for research…	+21	25	4.9k	22d
Coming back to: Cost per delivered dose, which is the number that matters Access › Pricing formulary data table compounding cost per milligram Under review On the subject in the title: Cost per delivered dose, which is the number that matters Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category…	+6	10	2.5k	19mo
Official shortage notices and what they authorise Access › Shortages compounding formulary shortage Posting this under the heading it deserves: Official shortage notices and what they authorise Everything below is what sits behind that. Trying to work out what would count as evidence on official shortage…	+106	119	18k	1mo
What a regulator's shortage notice actually authorises — what changed since Sourcing › Regulatory research use only EMA FDA compounding Solved The question in the title: What a regulator's shortage notice actually authorises — what changed since I will give what I have already checked below so nobody repeats it. Asking what a regulator's document…	+22	26	53k	7mo
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Access › Pricing compounding formulary cost per milligram Solved Price changes over 2025 and 2026, tabulated and dated — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Documenting an access outcome, dated,…	+147	156	18k	3mo